![Joshua Reed](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joshua Reed
Directeur Financier/CFO chez
ALKERMES PLC
Fortune : 625 075 $ au 31/05/2026
Profil
Mr. Joshua Reed is a Chief Financial Officer & Senior Vice President at Alkermes Plc and an Independent Director at Scholar Rock Holding Corp.
He is on the Board of Directors at Scholar Rock Holding Corp.
Mr. Reed was previously employed as a Chief Financial & Accounting Officer by Omega Therapeutics, Inc., a Chief Financial Officer & Treasurer by Aldeyra Therapeutics, Inc., a Vice President & Head-Finance Operations by Bristol Myers Squibb Co., and a Vice President-Strategic Business Development by JPMorgan Chase & Co. He received his undergraduate degree from Rutgers State University of New Jersey and an MBA from Stephen M.
Ross School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/07/2026 | 12 679 ( 0,01 % ) | 625 075 $ | 31/05/2026 |
Postes actifs de Joshua Reed
| Sociétés | Poste | Début |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Directeur/Membre du Conseil | 18/03/2021 |
| ALKERMES PLC | Directeur Financier/CFO | 15/09/2025 |
Anciens postes connus de Joshua Reed
| Sociétés | Poste | Fin |
|---|---|---|
| OMEA THER | Directeur Financier/CFO | 31/05/2024 |
| ALDEYRA THERAPEUTICS, INC. | Directeur Financier/CFO | 10/05/2022 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/07/2018 |
| JPMORGAN CHASE & CO. | Corporate Officer/Principal | 01/01/2005 |
Formation de Joshua Reed
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
71
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
JPMorgan Chase & Co.
 JPMorgan Chase & Co. Major BanksFinance Provides banking, asset management, investment banking, credit card and mortgage services | Finance |
Aldeyra Therapeutics, Inc.
 Aldeyra Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for eye diseases | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Scholar Rock Holding Corp.
 Scholar Rock Holding Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focused on the discovery, development and delivery medicines for neuromuscular, cardiometabolic disorders, cancer, fibrosis and iron-restricted anemia | Health Technology |
Omega Therapeutics, Inc.
 Omega Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for general and rare genetic diseases, immunology, inflammation, oncology and metabolic diseases | Health Technology |
Choisissez Zonebourse 
